The brokerage continues to like Mold-Tek Packaging given its strategy of timely capacity expansion and entry into high value products. The management’s focus on high margin Food and FMCG, foray into pharma segment and timely capacity addition for paints division would pave the way for future earnings growth.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
IDBI Capital Report
Mold-Tek Packaging Ltd.’s Q4 FY25 result was in-line with our estimates on all key parameters. The management expects double digit volume growth from 6.8% in FY25 to 10% in FY26.
Further, it is confident to clock revenue of more than Rs 250 million in Pharma segment in FY26E. The paint segment is expected to do better with positive trends in April and May’25.
The food and FMCG segment is estimated to grow at 15-20% in FY26. The company expects the Ebitda per Kg to touch Rs 42/Kg in coming few years led by higher pharma contribution.
We have broadly maintained our earnings estimates for FY26E/FY27E. Maintain Buy with a target price of Rs 715 (earlier Rs 709), assigning 20x PER on FY27E.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Ambuja, UltraTech, JK Cement — Systematix' Top Stock Picks In Cement Pack; Q1 Results Preview


Laurus Labs, Supriya Lifesciences, Divi’s Labs— DRChoksey's Top Stock Picks In Pharma Pack; Q1 Results Preview


TCS — Top Stock Pick By Systematix In IT Pack Ahead Of Q1 Results


IDBI Bank Shares Jump Nearly 5% After Disinvestment Said To Be In Final Phase
